← FDA DRUG APPROVALS

FDA ANDA · ANDA203741

NEBIVOLOL HYDROCHLORIDE

Sponsor: ALKEM LABS LTD

APPLICATION
ANDA203741
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-24
LATEST ACTION
2015-06-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 20MG BASE · TABLET · ORAL
NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 5MG BASE · TABLET · ORAL
NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL
NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 2.5MG BASE · TABLET · ORAL

Approval history

2015-06-24UNKNOWN · Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →